Biogen Inc. (BIIB) was upgraded to a "buy" by TheStreet's Quant Ratings service on Wednesday. This biotech name has made a chart that could be challenging to many traders and investors. Let's drill down and see if an easier approach to the long side can be found.
More from Stocks
Many people just can't resist the temptation of buying weakness as they are fooled into thinking it's a bargain, but there's no rush to buy anything right now.
These companies initially seemed to believe that regulators and law enforcement would drive out the illicit market dealers. That hasn't happened.
As we continue to implement social distancing, keep in mind that it will happen commercially as well.